Pricing Log in Create free account

Biogen Inc. (BIIB) vs Scilex Holding Company (SCLX)

Biogen Inc. and Scilex Holding Company are both Drug Manufacturers General companies. Biogen Inc. is the larger, with a market value of $34.8B against $19.8M — 1752.5× the size. Scilex Holding Company has negative trailing earnings, so its P/E is not meaningful; Biogen Inc. trades at 41.0×. Biogen Inc. grew revenue faster over the last twelve months: 0.31% against −28.6%. Biogen Inc. has the higher net margin (8.32% vs −1,418.5%) and the higher return on invested capital (3.11% vs 0.00%). Across the 18 metrics below, Biogen Inc. leads on 11 and Scilex Holding Company on 7.

Valuation

Metric BIIB SCLX Drug Manufacturers General median
P/E 40.96 n/m 24.54
P/S 3.43 0.62 3.39
P/B 1.82 n/m 5.00
Price to free cash flow 13.53 n/m 16.55
EV/EBITDA 15.66 n/m 13.82
EV/Sales 4.03 3.18 4.03
Earnings yield 2.44% (1,756.18%) 2.98%
Free cash flow yield 7.39% (91.35%) 4.46%

Profitability

Metric BIIB SCLX Drug Manufacturers General median
Gross margin 73.99% 55.50% 72.77%
Operating margin 12.35% (1,136.40%) 18.77%
Net margin 8.32% (1,418.45%) 8.27%
Free cash flow margin 25.33% (56.37%) 17.18%
Return on equity 4.58% 160.27% 5.87%
Return on assets 2.76% (265.83%) 2.57%
Return on invested capital 3.11% 0.00% 6.11%

Growth

Metric BIIB SCLX Drug Manufacturers General median
Revenue growth (TTM) 0.31% (28.55%) 6.66%
EPS growth (last fiscal year) (21.38%) (408.32%) 21.81%
Revenue growth, 5-year CAGR (5.96%) 5.13% 4.75%
Net income growth, 5-year CAGR (20.22%) 0.00% 0.00%

Health

Metric BIIB SCLX Drug Manufacturers General median
Debt to equity 0.39 (0.26) 0.63
Current ratio 1.87 0.07 1.32
Net debt to EBITDA 0.84 (0.27) 1.15

Dividend

Metric BIIB SCLX Drug Manufacturers General median
Dividend yield — — 2.33%
Payout ratio — — 0.59

Size

Metric BIIB SCLX Drug Manufacturers General median
Market cap 34.77b 19.84m 123.73b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack